In the search for immunoreagents appropriate for the histopathologic diagnosis of malignant B-cell lymphomas in routinely processed paraffin sections, a new monoclonal antibody, Ki-BI, was generated using a high-grade B-cell lymphoma as the immunogene. Ki-B5 is a mouse IgGl/kappa that recognizes five protein fractions of about 84,82,55,48, and 27 Kd after biosynthetic radiolabeling and immunoprecipitation. Protein fractions with the molecular weights of approximately 84 and 82 Kd were expressed on the cell surface and show that Ki-BI is probably unrelated t o CD45. It was possible through electron microscopy t o visualize the membrane-bound portion of Ki-B5. Extensive immunohistologic studies on normal human tissue and various neoplasias demonstrated the high specificity of Ki-B5 t o normal human B cells and a minor subgroup of plasma cells. Except for ML-2, which is a myelomonocytic human cell line, Ki-B5 exclusively recognized the 6-cell lineage, including EB-3, URING THE PAST 2 years an extensive effort was D made in the search for antihuman monoclonal antibodies (MoAbs) to paraffin-resistant antigens of high lineage restriction. The significance of such reagents for accurate diagnosis and subclassification of malignant lymphomas has been repeatedly appraised in detailed studies on routinely processed tissue sections.'3Z The moderate results achieved with the available paraffin-resistant antibodies3,4 encouraged continued search to reduce dependence on fresh tissue samples, which are difficult to handle, deliver poor morphologic results, and may propagate infections.
In the search for immunoreagents appropriate for the histopathologic diagnosis of malignant B-cell lymphomas in routinely processed paraffin sections, a new monoclonal antibody, Ki-BI, was generated using a high-grade B-cell lymphoma as the immunogene. Ki-B5 is a mouse IgGl/kappa that recognizes five protein fractions of about 84,82,55,48, and 27 Kd after biosynthetic radiolabeling and immunoprecipitation. Protein fractions with the molecular weights of approximately 84 and 82 Kd were expressed on the cell surface and show that Ki-BI is probably unrelated t o CD45. It was possible through electron microscopy t o visualize the membrane-bound portion of Ki-B5. Extensive immunohistologic studies on normal human tissue and various neoplasias demonstrated the high specificity of Ki-B5 t o normal human B cells and a minor subgroup of plasma cells. Except for ML-2, which is a myelomonocytic human cell line, Ki-B5 exclusively recognized the 6-cell lineage, including EB-3, URING THE PAST 2 years an extensive effort was D made in the search for antihuman monoclonal antibodies (MoAbs) to paraffin-resistant antigens of high lineage restriction. The significance of such reagents for accurate diagnosis and subclassification of malignant lymphomas has been repeatedly appraised in detailed studies on routinely processed tissue sections.'3Z The moderate results achieved with the available paraffin-resistant antibodies3,4 encouraged continued search to reduce dependence on fresh tissue samples, which are difficult to handle, deliver poor morphologic results, and may propagate infections.
The search has been especially fruitful in the identification of B-cell lymphomas in routinely processed sections. A few B-cell-reactive paraffin-resistant antibodies were soon made available, which facilitated the attainment of a diagnostic immunoprofile at least for the more common lymphoma s~btypes.~,~.'~ These reagents have a somewhat deviant spectrum of reactivity. The best results are obtained from a combined application of the available panel. In the present study we report on a new MoAb to a highly B-cell-restricted paraffin-resistant antigenic epitope.
MATERIAL AND METHODS
The MoAb Ki-BS was generated according to the method of Kohler and Milstein! BALB-c mice were immunized three times at weekly intervals with approximately 5 x lo6 suspended cells of a centroblastic lymphoma. Animals were boostered during 4 successive days before fusion. Spleen cells were fused with mouse-myeloma cell line X63lAg 8.653. Hybridoma were selected in hypoxanthine, aminopterin, thymidine (HAT)-medium and repeatedly cloned by limited dilution. Ascites containing the MoAb was raised in pristan primed mice.
Light-microscopic immunohistochemistry. Culture supernatants were tested on cryostat sections of human tonsils with the immune peroxidase method' or the immune alkaline phosphatase technique (APAAP).'" The immunohistologic reaction pattern was compared with that of established lineage-specific MoAb (Table 1) . Double staiiiings for two antigens were performed according to Feller et a] . ' The immunostaining of paraffin sections was performed accordGeneration of MoAb.
BALL-I, and NALM-1. All carcinomas, sarcomas, and malignant melanomas tested with Ki-B5 were negative. Although normal granulocytes and monocytes were constantly negative, three of eight myelomonocytic leukemias coreacted with this antibody. Eight of the 57 T-cell lymphomas studied were positive t o Ki-B5. Five were classified as lymphoblastic, two represented T,-CLL, and one was classified as immunoblastic T-cell lymphoma. Only 3 of 126 cases of B-cell lymphoma, including rare types not considered in the current classifications, were negative t o Ki-BB. Plasmacytomas were also negative, except for one case. Irrespective of the cases of lymphoblastic lymphoma and plasmacytoma, Ki-B5 represents a new monoclonal antibody appropriate for the diagnosis and immunophenotyping of malignant lymphomas in routinely processed paraffin sections. The MoAb Ki-B5 was tested on lymphatic and hematopoietic tissue (Table 1) . Human leukocyte fractions were separated by gradient centrifugation of defibrinated fresh blood samples from healthy donors (n = 3). Monocytes were separated by glass adherence.'* The separation of B cells from rosetting T lymphocytes was performed by incubation with neuraminidase-treated sheep erythrocytes and gradient centrifugation." The granulocytes were purified from the pellet after centrifugation. The purity of the separated leukocyte fractions was controlled by cell-specific MoAbs applied to cytospin preparations. Bone marrow cells were obtained from healthy donors (n = 3) to produce fresh smears.
Tissue samples were fixed in 10% paraformaldehyde, embedded in paraffin or paraplast, and 4-pm-thick sections were prepared. All samples were stained with hematoxylin and eosin, periodic-acidSchiff (PAS), Giemsa, and silver impregnation. Fifty-three cases of carcinoma (breast, colon, stomach, uterus, skin, bladder, prostate gland, ovary), four cases of sarcoma, three cases of malignant melanoma, and 97 cases of low-grade and 84 cases of high-grade malignant lymphoma comprising 126 cases of B-cell and 57 cases of T-cell origin were included. All lymphoma cases were obtained from the files of the Lymph Node Registry in Kiel and were classified according to Stansfeld et (n = 57), and myelomonocytic leukemia (n = 8) were investigated.
These entities are listed in Tables 2 and 3 . In addition, a group of rare types of B-cell lymphoma were studied. These cases were classified as hairy cell leukemia (HCL, n = l), prolymphocytic leukemia (B-PLL, n = l), monocytoid B-cell lymphoma (n = ,)?'I low-grade B-cell lymphoma of the MALT (n = 19),22T-cell-rich high-grade B-cell lymphoma (n = 4),' high-grade Burkitt type or B-immunoblastic lymphoma occurring in acquired immodeficiency syndrome (AIDS) or otherwise immunocompromised patients (n = 3),24.2s and high-grade large cell B-lymphoma of the mediastinum with sclerosis (n = 9).z6zx In addition, cytospin preparations of 12 cases of acute myelomonocytic leukemia were studied.
The following normal human tissues were tested in cryostat sections and routinely processed paraffin sections: skin, neural tissue, cardiovascular tissue, tissue from the respiratory tract, gastrointestinal tissue, hepatobiliary tissue, endocrine glands, exocrine glands, muscle, synovia, bone, cartilage, and urogenital tract.
To test the reactivity of the interdigitating dendritic (reticulum) cells, five cases of dermatopathic lymphadenopathy were investigated. Furthermore, three cases of necrotizing lymphadenitis (Kikuchi-Fujimoto disease), five cases of Piringer's lymphadenitis, and three cases of tuberculous lymphadenitis were included to study the immunostaining behavior of the plasmacytoid monocytes," cells of immature sinus histiocytosis, epithelioid histiocytes, Langerhans' giant cells, and macrophages (Table 1) .
Fresh tonsils ectomized for follicular hyperplasia (n = 5) were minced and passed through a 20-km mesh sieve. The cells were suspended in RPMI (SeromedBiochrom KG, Berlin, Germany), centrifuged at 1, OOOg for IO minutes, fixed in 2.5% glutaraldehyde for IO minutes and rinsed three times in phosphate buffer. After subsequent centrifugation, pellets were incubated in Ki-B5 dilutions ranging from 1:lOO to 1:5,000 for 25 minutes. Peroxidase-conjugated rabbit antimouse Ig (DAKO) in a dilution of 1:20 was used as a secondary antibody, and peroxidase-conjugated goat antirabbit Ig (Medac, Hamburg, Germany) at a dilution of 1:200 was used as a tertiary antibody. The cells were centrifuged and washed in Tris-NaC1 buffer after each incubation. The diaminobenzidine (DAB)-reaction was developed and the cells were postfixed in 1% (gimL) osmium tetroxide for 10 minutes. After incubation with 6% (g/mL) bovine albumin and 12.5% (g/mL) glutaraldehyde the cells were dehydrated in Immune electron microscopy. The human lymphoblastoid cell line WI-L2-729-HF2, which is strongly positive to Ki-B5, was labeled overnight with 0.1 mCi of L-["'S] methionine (Amersham Buchler, Braunschweig, Germany). The radiolabeled cells were washed twice with cold phosphate-buffered saline (PBS), resuspended in 100 pL PBS containing 0.1 mmol/L phenylmethylsulfonylfluoride (Serva, Heidelberg, Germany) and incubated for 30 minutes with 900 FL lysis buffer containing 2% Triton X 100, 1 mmol/L EDTA in PBS, adjusted to pH 8. The lysate was centrifuged twice at 15,OOOg for 15 minutes. The immunoprecipitation of the antigen was performed by Ki-B5 coupled to antimouse Ig Protein A-Sepharose CL-4B (Biochrom, Berlin, Germany) as described by Hansen et aL3"
As negative controls, immunoprecipitations were performed with Protein A-Sepharose CL-4B coupled to antimouse Ig only.
Molecular weight determination of protein fractions expressed on the cell surface was performed by incubating intact radiolabeled WI-L2-729-HF2 with MoAb Ki-B5 for 1 hour following the procedure of Hansen et aI."The cells were then washed three times with ice-cold PBS and subsequently lysed as described above. Immunoprecipitation was performed with a-mouse Ig coupled to Protein A-Sepharose CL-4B.
The Ki-B5 antigen was analysed under reducing conditions with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using continuous gradient gels ranging from 7.5% to 15%. A commercial molecular weight marker kit was run as reference (Kit No. 4, Serva). Gels were stained with Coomassie blue (Sigma, Munich, Germany), rinsed for 30 minutes in Amplify (Amersham Buchler) and radiographed on preflashed X-ray films (Kodak-XOmat AR, Stuttgart, Germany).
In addition to tissue samples, typical cell lines widely accepted in experimental use were studied on an immunocytochemical basis. As representative B cells the cell lines NALM-1, BALL-1, EB-3, and U-266 were selected. MOLT-4, a lymphoblastoid line, served Biosynthetic radiolabeling and immunoprecipitation.
as a T-cell line. Furthermore, U-937, TPM-1-0, K562, ML-2, and HL-60 were used as myelomonocytic lines. Epithelial lines were OAC 7-18-3, 1-6-2, and 3-8-2 established from ovarian adenocarcinomas (Table 4) .
To determine the Ig class, dilutions of the culture supernatant were matched against rabbit antimouse Ig isotypes (Nordic, Tilburg, Netherlands) in immunoprecipitation tests.
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RESULTS
Of a total of 150 supernatants of the primary cultures only one showed a strong immunoreactivity with B follicles in cryostat sections of tonsils. Likewise, in routinely processed paraffin sections an identical reaction pattern could be detected. Cloned hybrids produced in ascites high-titer antibody up to a dilution of 1:8000 using PBS. Ki-B5 dilutions showed immunoprecipitation lines with rabbit antimouse IgGl/K, exclusively.
The MoAb Ki-BS showed a highly restricted reactivity in human tissue. All tissue types histochemically matched with this reagent showed a negative reaction. The tissues tested included skin, neural tissue, cardiovascular tissue, tissue from the respiratory tract, gastrointestinal tissue, hepatobiliary tissue, endocrine glands, exocrine glands, muscle, synovia, bone cartilage, and urogenital tract. This finding was true not only of neural epithelial and connective tissue but also of muscle, bone, and cartilage. The reactive cells were mainly localized in lymphatic tissue and bone marrow (Table 1) .
In tonsil-and gut-associated lymphoid tissue, Ki-B5 immunostained nearly all follicle mantle cells as well as about 70% of germinal center cells. Within the interfollicular areas 20% to 30% of small lymphocytes were positive. The reaction pattern of Ki-B5 was well in accordance with that of anti-CD22. However, the latter recognizes all lymphoid cells of germinal centers. About 20% of plasma cells were recognized by Ki-BS. In thymus tissue sections, small accumulations of CD22-positive lymphocytes were Selection of Ki-BS.
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immunostained by Ki-BS. In the spleen the reactive cells were restricted to B follicles that were strongly immunolabeled by Ki-BS. The reaction pattern here also corresponded to that of anti-CD22. Within the red pulp a few small accumulations of plasma cells were positive. All other structures showed a negative reaction. In lymph node sections (Fig 1A and B) Ki-BS immunostained nearly all of the follicle mantle lymphocytes and about 70% of the germinal center cells. Within the interfollicular areas and in the medullary pulp about 20% of lymphocytes and some plasma cells reacted positively, which is well in line with the reactivity of anti-CD22. T cells, tingible body macrophages, interdigitating reticulum cells, follicular dendritic cells, sinus lining cells, and vascular and connective tissue cells were all negative (Table 1 ). In five cases of dermatopathic lymphadenopathy the number of reactive lymphocytes was clearly reduced. The large number of interdigitating reticulum cells and other macrophages were negative. In three cases of necrotizing lymphadenitis (Kikuchi) the so-called plasmacytoid "T" cells or plasmacytoid monocytes were partly positive. The epithelioid cells seen in the five cases of Piringer lymphadenitis, a lymph node disorder mainly caused by toxoplasmosis and exhibiting a characteristic histologic picture, and the three cases of tuberculosis were negative. By contrast, the cells of immature sinus histiocytosis, a sinus B-cell reaction, were positive in all cases of Piringer's lymphadenitis. 1i1 addition, an undefined cohort of tissue mast cells showed weak reactivity with Ki-BS. All these results are in agreement with the reaction pattern of anti-CD22.
Four B-cell lines were reactive with Ki-BS, whereas T-cell, myeloid, and carcinoma cell lines remained negative ( Table 4) .
In cytospins of separated B cells ( Table 5 ) over 80% of lymphocytes were reactive with Ki-BS or anti-CD22 and a similar percentage when the cells were immunostained for both antibodies simultaneously. In cytospins subjected to combined staining with anti-CD3 and Ki-BS, no doublereactive lymphocytes were detectable. In cytospins from separated T cells over 90% of the cells were positive for anti-CD3 and less than 10% for Ki-BS and anti-CD22. When anti-CD3 and Ki-BS were combined, T-cell cytospins showed no cells reactive to both antibodies. Paraffin sections of 60 different non-hematopoietic malignant tumors subjected to Ki-BS staining were negative in all cases. This finding was true for all 53 cases of carcinoma as well as for the three cases of malignant melanoma and the four various types of sarcomas. Ki-BS did not react with non-hematopoietic neoplasias investigated on paraffin and frozen sections including the following: carcinoma of the breast, colon, stomach, uterus, skin, bladder, prostate gland, ovary, and malignant melanoma and sarcoma.
Ki-BS strongly reacted with neoplastic B lymphocytes of B-CLL, LP-IC, CB/CC, HCL, and CC in all 34 cases studied on paraffin sections. An identical result was achieved using fresh frozen material in 30 cases, as summarized in Table 2 .
HCL, studied in a single case, was also positive. Of six cases of plasmacytoma studied on paraffin material, one was positive. Among the high-grade B-cell lymphomas, the cases of CB reacted positively in all 27 instances, irrespective of the type of preservation (Fig 2) . Of the 14 cases of B-IB (Fig 3) studied in eight frozen and 14 paraffin sections, only one case was negative. In another case the reaction was extremely weak. Cases of B-LB were all recognized by Ki-BS on frozen sections as well as after paraffin processing. All Burkitt lymphoma cases and the large cell anaplastic lymphomas with B-cell features such as monotypic Ig content or CD22 expression were recognized by Ki-BS. The reactivity of Ki-BS to various B-cell lymphomas listed in the Non-hematopoietic neoplasias.
Hematopoietic neoplasias.
Kiel classification and working formulation are surveyed in Table 2 for frozen and paraffin material. Of the 39 cases of rarer types of B-cell lymphoma, most of which are not included in the current classifications, only two cases were weakly positive or even completely negative to Ki-BS. These two cases were diagnosed as high-grade large cell B lymphoma of the mediastinum with sclerosis.
Of the eight T-LB lymphomas studied on frozen sections and/or cytospins, one was positive to Ki-BS. However, using paraffin sections five of seven cases reacted positively. Two of four cases of T,-CLL were positive for Ki-BS. By contrast, all samples studied from T-CLL, T-zone lymphoma (Fig 4) , lymphoepithelioid lymphoma, T-cell lymphoma of AILD type, pleomorphic type of PTCL, and large cell anaplastic T-cell lymphoma were negative. However, a single case of T-IB studied in paraffin sections proved to be Ki-BS-positive. Three of eight myelomonocytic leukemias were also positive in repeated examinations. These findings are presented in Table 3 .
In immune electron microscopic studies Ki-BS showed a negative reaction with the majority of tissue types. The reactivity was always confined to the outer cell membrane of small lymphocytes and of the germinal center cells. The inner surface of the cytoplasmic membrane, intracytoplasmic structures, and the nucleus regularly remained nonreactive (Fig SA and B) . (Fig 6) . Lymphocyte preparations obtained from fresh human tonsils, as the source of Ki-BS antigen, showed the same results.
Additional experiments showed the expression of only two protein fractions with molecular weights of 84 and 82 Kd on the surface of WI-L2-729-HF2 cells (Fig 6) .
DISCUSSION
Ki-BS is a MoAb of IgGl isotype that detects a formalinresistant epitope on human B lymphocytes. The reactive antigen consists of five protein fractions with a molecular weight of 84, 82, 55, 48, and 27 Kd under reducing conditions. The protein fractions with molecular weights of 84 and 82 Kd were expressed on the cell surface. In light of these data, Ki-B5-reactive antigen seems to be unrelated to CD45. In all electron microscopic studies performed to date, Ki-BS positivity was localized on the outer surface of cytoplasmic membranes of the reactive cells. In lymphoid tissue, Ki-BS reactivity was restricted to the follicle mantle cells, to about 70% of the germinal center cells, and to the interfollicular B cells. In this respect, and considering lymphocytes of the peripheral blood, Ki-BS was fairly similar to CD22. Ki-BS-positive cells were never found to coreact with anti-CD3. Also, normal monocytes, granulocytes, and their marrow precursors were shown to be negative with this antibody. Using permanent human cell lines the reactivity was found to be confined to EB-3, BALL-1, and NALM-1, which were established from cases of B-cell lymphoma. Accordingly, these cell types are positive to CD22 in addition to Ki-BS. The plasmacytic cell line U-266 and, with the exception of ML-2, all T-lymphoid, myelomonocytic, and epithelial cell lines were regularly negative.
Ki-BS did not show any coreactivity with cases of carcinoma, sarcoma, or malignant melanoma included in this study.
Although no coreactivity was observed with normal granulocytes or blood monocytes, about one-third of myeloid or myelomonocytic leukemias tested with this antibody on fresh cytocentrifuge slides were found to be partially positive.
As in normal B cells, the overwhelming majority of B-cell
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From neoplasias were positive to Ki-B5. Except for cases of plasmacytoma, in which only one of six reacted positively, all cases of low-grade B-cell lymphoma included in this study were clearly positive. Similarly, a positive reaction was detected in 58 of 60 cases of high-grade B-cell lymphoma. Only one case each of immunoblastic and lymphoblastic subtypes failed to react. All cases of centroblastic, Burkitt's type, and large cell anaplastic B-cell lymphoma were regularly positive. Ki-BS was found to be an appropriate reagent also for the diagnosis of the rarer types of B-cell lymphoma such as monocytoid B-cell lymphoma:' lowgrade B-cell lymphoma of the MALT:' T-cell-rich highgrade B-cell lymphoma,= and high-grade B-immunoblastic or Burkitt type lymphoma occurring in patients with immune deficiency syndrome^."*^ Similarly, of the eight cases of the recently described high-grade large cell B lymphoma of the mediastinum with s~lerosis,2'-~ only two exhibited weak or no reactivity to Ki-B5, whereas all other cases were clearly positive.
Ki-B5 proved to be useful in the distinction of B-cell neoplasias from T-cell lymphomas. Of a total of 57 T-cell lymphomas, eight cases were positive to Ki-B5. All cases of T-cell lymphomas of AILD-type, T-zone lymphoma, and lymphoepithelioid T-cell lymphoma3' were negative. In the same manner, all pleomorphic PTCLs irrespective of their cytologic features showed a negative reaction. This result was also the case with the large cell anaplastic lymphoma of the T-cell type?' Using paraffin sections one case of T-immunoblastic lymphoma was partially positive. Another coreactivity was observed in two cases of T,-CLL, although normal T, lymphocytes were regularly negative. Among the T-cell lymphomas, the prethymic and thymic subtypes included in the lymphoblastic cohort showed a peculiar behavior. On fresh cytocentrifuge preparations or on frozen sections, only a single case reacted positively. However, in paraffin sections, a considerably higher number of T-lymphoblastic lymphomas were found to be positive. Altogether, five of seven coreacted with Ki-B5.
Among the available antibodies with specificities against paraffin-resistant epitopes, those recognizing CD45' or its restricted variants (CD45r) have contributed considerably to the diagnostic possibilities in histopathology. At least two antibodies of this group, MBlJ3 and Ki-B3,5" are largely restricted to the epitopes expressed by human B cells. Ki-B3 recognizes a cell surface protein of 220 Kd molecular weight. A similar reagent is MBl,333 which is an IgGl recognizing an epitope of CD45r with a molecular weight of 200 Kd. Other related antibodies, such as 4KB5 and F8-11-13,'5~36 have been shown to be directed against the same antigen.
Another paraffin-reactive B-cell reagent, designated MB2: was reported to reliably discriminate between T and B lymphocytes, although coreactivities with epidermal and other epithelial tissue types and germ cells may limit its applicability. MB2 recognizes an intracytoplasmic antigen of 28 Kd. In contrast to the other B-cell reagents, some MoAbs seem to mark cytoplasmic determinants. One anti-
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body of this line is LN1, which preferentially detects germinal center B cells. In Western blot analysis, LN1-reactive antigen shows eight bands within a range of 45 and 85 Kd.
A further paraffin-resistant epitope of the leukocytecommon antigen restricted to B cells is recognized by the MoAb L26, which was introduced by Ishii et al?* This antigen is also markedly expressed on germinal center cells such as centrocytes, centroblasts, and immunoblasts. B lymphocytes such as those of follicle mantle type and of the medullary pulp, or of the marginal zone, show only a weak or irregular reactivity. In accordance with this finding, the overwhelming majority of blastic or high-grade malignant B-cell lymphomas represent the main diagnostic domain of L26. This finding is best evidenced by comparing ascertained cases of B-cell lymphoma studied with different reagents. In such an attempt, Linder et a139 could show that L26 reacted with over 89% of the 87 cases of B-cell lymphoma, Only a few cases of B-CLL, LP-IC, and CB/CC turned out to be negative with this antibody. Coreactivity with T-cell lymphomas was rare, being restricted to only 5%. L26 did not immunostain nonlymphomatous tumors such as carcinomas, neurogenic sarcomas, malignant melanomas, or fibrohistiocytic neoplasias. Of the B-cell neoplasms only plasmacytoma was regularly nonreactive to L26. Ki-BS showed a reactivity similar to that of L26 as far as high-grade lymphomas are concerned. However, lymphocytic low-grade B-cell lymphomas showed a considerably stronger reactivity to Ki-BS in all cases studied. The immunochemical data and the clear difference in the intensity and the immunohistochemical distribution pattern are reliable evidence that Ki-BS recognizes an antigenic epitope different from that of other B-cell reagents now in use.
B-cell neoplasms comprise the greater part of malignant lymphomas and show a broader range of diversity than neoplasias of T lineage do. This finding is also expected to be the case for the immune features expressed by the individual B-cell subcohorts. Thus, it is advisable to apply a well-chosen panel of B-cell-reactive antibodies to cover the whole spectrum, as emphasized by other author^?^.^^ In addition, it is hoped that the use of an appropriate array of immune reagents will also enable classification of the high-grade B-cell lymphomas along their natural line of differentiation.
